T helper type 17 in psoriasis: From basic immunology to clinical practice
Psoriasis is a chronic inflammatory disease mediated by a complex interplay between immune system and keratinocytes. Initially considered as a keratinocyte proliferation/differentiation disorder, an immune dysregulation was confirmed after the successful treatment of psoriasis with cyclosporine. The...
Saved in:
Main Authors: | Hsien-Yi Chiu (Author), Yu-Pin Cheng (Author), Tsen-Fang Tsai (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2012-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nodal T-Follicular Helper Cell Lymphoma, Angioimmunoblastic-Type, Diagnosed in a Patient with Psoriasis Following COVID-19 Vaccination under Adalimumab Treatment: A Causal Association?
by: Chang-Yu Hsieh, et al.
Published: (2024) -
Practical experience of ustekinumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to previous tumor necrosis factor blockers
by: Tzu-Chang Wang, et al.
Published: (2015) -
Reactivation of Epstein-Barr virus and cytomegalovirus in patients with psoriasis after ustekinumab treatment
by: Chang-Yu Hsieh, et al.
Published: (2020) -
Effectiveness and safety of secukinumab for psoriasis in real-world practice: analysis of subgroups stratified by prior biologic failure or reimbursement
by: Tzong-Yun Ger, et al.
Published: (2019) -
Secukinumab in psoriasis patients with prior ustekinumab treatment: Results of a single-center experience
by: Ting-Shun Wang, et al.
Published: (2017)